Works by Wheeler, David C.


Results: 209
    1
    2

    Randomized Trial Comparing Proactive, High-Dose versus Reactive, Low-Dose Intravenous Iron Supplementation in Hemodialysis (PIVOTAL): Study Design and Baseline Data.

    Published in:
    2018
    By:
    • Macdougall, Iain C.;
    • White, Claire;
    • Anker, Stefan D.;
    • Bhandari, Sunil;
    • Farrington, Kenneth;
    • Kalra, Philip A.;
    • McMurray, John J.V.;
    • Murray, Heather;
    • Steenkamp, Retha;
    • Tomson, Charles R.V.;
    • Wheeler, David C.;
    • Winearls, Christopher G.;
    • Ford, Ian;
    • Macdougall, Iain C;
    • Anker, Stefan D;
    • Kalra, Philip A;
    • McMurray, John J V;
    • Tomson, Charles R V;
    • Wheeler, David C;
    • Winearls, Christopher G
    Publication type:
    journal article
    3

    Recurrent event analyses in patients receiving maintenance dialysis and the effect of higher‐ versus lower‐dose chronic intravenous iron therapy: A report focusing on heart failure events from the PIVOTAL trial.

    Published in:
    European Journal of Heart Failure, 2025, v. 27, n. 6, p. 1007, doi. 10.1002/ejhf.3670
    By:
    • Anker, Stefan D.;
    • Robertson, Michele;
    • McMurray, John J.V.;
    • Jhund, Pardeep S.;
    • White, Claire;
    • Reid, Chante;
    • Bhandari, Sunil;
    • Farrington, Ken;
    • Kalra, Philip A.;
    • Talha, Khawaja M.;
    • Mark, Patrick B.;
    • Tomson, Charles R.V.;
    • Wheeler, David C.;
    • Winearls, Chris G.;
    • Macdougall, Iain C.;
    • Ford, Ian
    Publication type:
    Article
    4
    5
    6
    7

    Geographic and racial variability in kidney, cardiovascular and safety outcomes with canagliflozin: A secondary analysis of the CREDENCE randomized trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2024, v. 26, n. 9, p. 3530, doi. 10.1111/dom.15685
    By:
    • Cardoza, Kathryn;
    • Kang, Amy;
    • Smyth, Brendan;
    • Yi, Tae Won;
    • Pollock, Carol;
    • Agarwal, Rajiv;
    • Bakris, George;
    • Charytan, David M.;
    • de Zeeuw, Dick;
    • Wheeler, David C.;
    • Zhang, Hong;
    • Cannon, Christopher P.;
    • Perkovic, Vlado;
    • Arnott, Clare;
    • Levin, Adeera;
    • Mahaffey, Kenneth W.
    Publication type:
    Article
    8
    9

    The sodium‐glucose cotransporter‐2 inhibitor canagliflozin does not increase risk of non‐genital skin and soft tissue infections in people with type 2 diabetes mellitus: A pooled post hoc analysis from the CANVAS Program and CREDENCE randomized double‐blind trials

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 8, p. 2151, doi. 10.1111/dom.15091
    By:
    • Kang, Amy;
    • Smyth, Brendan;
    • Neuen, Brendon L.;
    • Heerspink, Hiddo J. L.;
    • Di Tanna, Gian Luca;
    • Zhang, Hong;
    • Arnott, Clare;
    • Hockham, Carinna;
    • Agarwal, Rajiv;
    • Bakris, George;
    • Charytan, David M.;
    • de Zeeuw, Dick;
    • Greene, Tom;
    • Levin, Adeera;
    • Pollock, Carol;
    • Wheeler, David C.;
    • Mahaffey, Kenneth W.;
    • Perkovic, Vlado;
    • Jardine, Meg J.
    Publication type:
    Article
    10

    Effects of canagliflozin on cardiovascular and kidney events in patients with chronic kidney disease with and without peripheral arterial disease: Integrated analysis from the CANVAS Program and CREDENCE trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 7, p. 2043, doi. 10.1111/dom.15065
    By:
    • Yi, Tae Won;
    • Wong, Michelle M.Y.;
    • Neuen, Brendon L.;
    • Arnott, Clare;
    • Poirier, Paul;
    • Seufert, Jochen;
    • Slee, April;
    • Rapattoni, Wally;
    • Ang, Fernando G.;
    • Wheeler, David C.;
    • Mahaffey, Kenneth W.;
    • Perkovic, Vlado;
    • Levin, Adeera
    Publication type:
    Article
    11
    12
    13

    Quételet (body mass) index and effects of dapagliflozin in chronic kidney disease.

    Published in:
    Diabetes, Obesity & Metabolism, 2022, v. 24, n. 5, p. 827, doi. 10.1111/dom.14641
    By:
    • Chertow, Glenn M.;
    • Vart, Priya;
    • Jongs, Niels;
    • Langkilde, Anna Maria;
    • McMurray, John J. V.;
    • Correa‐Rotter, Ricardo;
    • Rossing, Peter;
    • Sjöström, C. David;
    • Stefansson, Bergur V.;
    • Toto, Robert D.;
    • Wheeler, David C.;
    • Heerspink, Hiddo J. L.
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29

    A note on performance metrics for the Kidney Failure Risk Equation.

    Published in:
    Nephrology Dialysis Transplantation, 2024, v. 39, n. 9, p. 1523, doi. 10.1093/ndt/gfae098
    By:
    • Ålund, Oskar;
    • Unwin, Robert;
    • Challis, Benjamin;
    • Kalra, Philip A;
    • Taal, Maarten W;
    • Wheeler, David C;
    • Fraser, Simon D S;
    • Cockwell, Paul;
    • Söderberg, Magnus
    Publication type:
    Article
    30

    Efficacy and safety of zibotentan and dapagliflozin in patients with chronic kidney disease: study design and baseline characteristics of the ZENITH-CKD trial.

    Published in:
    Nephrology Dialysis Transplantation, 2024, v. 39, n. 3, p. 414, doi. 10.1093/ndt/gfad183
    By:
    • Heerspink, Hiddo J L;
    • Greasley, Peter J;
    • Ahlström, Christine;
    • Althage, Magnus;
    • Dwyer, Jamie P;
    • Law, Gordon;
    • Wijkmark, Emma;
    • Lin, Min;
    • Mercier, Anne-Kristina;
    • Sunnåker, Mikael;
    • Turton, Michelle;
    • Wheeler, David C;
    • Ambery, Philip
    Publication type:
    Article
    31

    Associations with age and glomerular filtration rate in a referred population with chronic kidney disease: methods and baseline data from a UK multicentre cohort study (NURTuRE-CKD).

    Published in:
    Nephrology Dialysis Transplantation, 2023, v. 38, n. 11, p. 2617, doi. 10.1093/ndt/gfad110
    By:
    • Taal, Maarten W;
    • Lucas, Bethany;
    • Roderick, Paul;
    • Cockwell, Paul;
    • Wheeler, David C;
    • Saleem, Moin A;
    • Fraser, Simon D S;
    • Banks, Rosamonde E;
    • Johnson, Tim;
    • Hale, Lorna J;
    • Andag, Uwe;
    • Skroblin, Philipp;
    • Bayerlova, Michaela;
    • Unwin, Robert;
    • Vuilleumier, Nicolas;
    • Dusaulcy, Rodolphe;
    • Robertson, Fiona;
    • Colby, Elizabeth;
    • Pitcher, David;
    • Braddon, Fiona
    Publication type:
    Article
    32

    Design and population of the VALOR-CKD study: a multicenter, randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of veverimer in slowing progression of chronic kidney disease in patients with metabolic acidosis.

    Published in:
    Nephrology Dialysis Transplantation, 2023, v. 38, n. 6, p. 1448, doi. 10.1093/ndt/gfac289
    By:
    • Mathur, Vandana S;
    • Bushinsky, David A;
    • Inker, Lesley;
    • Klaerner, Gerrit;
    • Li, Elizabeth;
    • Parsell, Dawn;
    • Perkovic, Vlado;
    • Stasiv, Yuri;
    • Walker, Michael;
    • Wesson, Donald E;
    • Wheeler, David C;
    • Tangri, Navdeep
    Publication type:
    Article
    33

    Extrapolated longer-term effects of the DAPA-CKD trial: a modelling analysis.

    Published in:
    Nephrology Dialysis Transplantation, 2023, v. 38, n. 5, p. 1260, doi. 10.1093/ndt/gfac280
    By:
    • McEwan, Phil;
    • Boyce, Rebecca;
    • Sanchez, Juan Jose Garcia;
    • Sjöström, C David;
    • Stefansson, Bergur;
    • Nolan, Stephen;
    • Correa-Rotter, Ricardo;
    • Rossing, Peter;
    • Chertow, Glenn M;
    • McMurray, John J V;
    • Wheeler, David C;
    • Heerspink, Hiddo J L
    Publication type:
    Article
    34

    ASCEND-ND trial: study design and participant characteristics.

    Published in:
    Nephrology Dialysis Transplantation, 2022, v. 37, n. 11, p. 2157, doi. 10.1093/ndt/gfab318
    By:
    • Perkovic, Vlado;
    • Blackorby, Allison;
    • Cizman, Borut;
    • Carroll, Kevin;
    • Cobitz, Alexander R;
    • Davies, Rich;
    • DiMino, Tara L;
    • Jha, Vivekanand;
    • Johansen, Kirsten L;
    • Lopes, Renato D;
    • Kler, Lata;
    • Macdougall, Iain C;
    • McMurray, John J V;
    • Meadowcroft, Amy M;
    • Obrador, Gregorio T;
    • Solomon, Scott;
    • Taft, Lin;
    • Wanner, Christoph;
    • Waikar, Sushrut S;
    • Wheeler, David C
    Publication type:
    Article
    35

    Safety and efficacy of dapagliflozin in patients with focal segmental glomerulosclerosis: a prespecified analysis of the dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial.

    Published in:
    Nephrology Dialysis Transplantation, 2022, v. 37, n. 9, p. 1647, doi. 10.1093/ndt/gfab335
    By:
    • Wheeler, David C;
    • Jongs, Niels;
    • Stefansson, Bergur V;
    • Chertow, Glenn M;
    • Greene, Tom;
    • Hou, Fan Fan;
    • Langkilde, Anna Maria;
    • McMurray, John J V;
    • Rossing, Peter;
    • Nowicki, Michal;
    • Wittmann, István;
    • Correa-Rotter, Ricardo;
    • Sjöström, C David;
    • Toto, Robert D;
    • Heerspink, Hiddo J L;
    • Investigators, DAPA-CKD Trial Committees and
    Publication type:
    Article
    36

    Study design and baseline characteristics of patients on dialysis in the ASCEND-D trial.

    Published in:
    Nephrology Dialysis Transplantation, 2022, v. 37, n. 5, p. 960, doi. 10.1093/ndt/gfab065
    By:
    • Singh, Ajay K;
    • Blackorby, Allison;
    • Cizman, Borut;
    • Carroll, Kevin;
    • Cobitz, Alexander R;
    • Davies, Rich;
    • Jha, Vivekanand;
    • Johansen, Kirsten L;
    • Lopes, Renato D;
    • Kler, Lata;
    • Macdougall, Iain C;
    • McMurray, John J V;
    • Meadowcroft, Amy M;
    • Obrador, Gregorio T;
    • Perkovic, Vlado;
    • Solomon, Scott;
    • Wanner, Christoph;
    • Waikar, Sushrut S;
    • Wheeler, David C;
    • Wiecek, Andrzej
    Publication type:
    Article
    37

    Routine serum biomarkers, but not dual-energy X-ray absorptiometry, correlate with cortical bone mineral density in children and young adults with chronic kidney disease.

    Published in:
    Nephrology Dialysis Transplantation, 2021, v. 36, n. 10, p. 1872, doi. 10.1093/ndt/gfaa199
    By:
    • Lalayiannis, Alexander D;
    • Crabtree, Nicola J;
    • Ferro, Charles J;
    • Askiti, Varvara;
    • Mitsioni, Andromachi;
    • Biassoni, Lorenzo;
    • Kaur, Amrit;
    • Sinha, Manish D;
    • Wheeler, David C;
    • Duncan, Neill D;
    • Popoola, Joyce;
    • Milford, David V;
    • Long, Jin;
    • Leonard, Mary Beth;
    • Fewtrell, Mary;
    • Shroff, Rukshana
    Publication type:
    Article
    38

    Estradiol and mortality in women with end-stage kidney disease.

    Published in:
    Nephrology Dialysis Transplantation, 2020, v. 35, n. 11, p. 1965, doi. 10.1093/ndt/gfaa126
    By:
    • Ramesh, Sharanya;
    • James, Matthew T;
    • Holroyd-Leduc, Jayna M;
    • Wilton, Stephen B;
    • Seely, Ellen W;
    • Hemmelgarn, Brenda R;
    • Tonelli, Marcello;
    • Wheeler, David C;
    • Ahmed, Sofia B
    Publication type:
    Article
    39

    The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics.

    Published in:
    Nephrology Dialysis Transplantation, 2020, v. 35, n. 10, p. 1700, doi. 10.1093/ndt/gfaa234
    By:
    • Wheeler, David C;
    • Stefansson, Bergur V;
    • Batiushin, Mikhail;
    • Bilchenko, Oleksandr;
    • Cherney, David Z I;
    • Chertow, Glenn M;
    • Douthat, Walter;
    • Dwyer, Jamie P;
    • Escudero, Elizabeth;
    • Pecoits-Filho, Roberto;
    • Furuland, Hans;
    • Górriz, José Luis;
    • Greene, Tom;
    • Haller, Hermann;
    • Hou, Fan Fan;
    • Kang, Shin-Wook;
    • Isidto, Rey;
    • Khullar, Dinesh;
    • Mark, Patrick B;
    • McMurray, John J V
    Publication type:
    Article
    40
    41

    Rationale and protocol of the Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial.

    Published in:
    Nephrology Dialysis Transplantation, 2020, v. 35, n. 2, p. 274, doi. 10.1093/ndt/gfz290
    By:
    • Heerspink, Hiddo J L;
    • Stefansson, Bergur V;
    • Chertow, Glenn M;
    • Correa-Rotter, Ricardo;
    • Greene, Tom;
    • Hou, Fan-Fan;
    • Lindberg, Magnus;
    • McMurray, John;
    • Rossing, Peter;
    • Toto, Roberto;
    • Langkilde, Anna Maria;
    • Wheeler, David C;
    • Investigators, for the DAPA-CKD
    Publication type:
    Article
    42
    43
    44
    45

    Erratum.

    Published in:
    2018
    By:
    • Dekkers, Claire C J;
    • Wheeler, David C;
    • Sjöström, C David;
    • Stefansson, Bergur V;
    • Cain, Valerie;
    • Heerspink, Hiddo J L
    Publication type:
    Correction Notice
    46

    Prognostic utility of estimated albumin excretion rate in chronic kidney disease: results from the Study of Heart and Renal Protection.

    Published in:
    Nephrology Dialysis Transplantation, 2018, v. 33, n. 2, p. 257, doi. 10.1093/ndt/gfw396
    By:
    • Mafham, Marion M.;
    • Staplin, Natalie;
    • Emberson, Jonathan;
    • Haynes, Richard;
    • Herrington, William;
    • Reith, Christina;
    • Wanner, Christoph;
    • Walker, Robert;
    • Cass, Alan;
    • Levin, Adeera;
    • Fellström, Bengt;
    • Lixin Jiang;
    • Holdaas, Hallvard;
    • Kasiske, Bertram;
    • Wheeler, David C.;
    • Landray, Martin J.;
    • Baigent, Colin
    Publication type:
    Article
    47
    48
    49
    50

    Baseline characteristics of subjects enrolled in the Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) trial.

    Published in:
    Nephrology Dialysis Transplantation, 2012, v. 27, n. 7, p. 2872, doi. 10.1093/ndt/gfr777
    By:
    • Chertow, Glenn M.;
    • Correa-Rotter, Ricardo;
    • Block, Geoffrey A.;
    • Drueke, Tilman B.;
    • Floege, Jürgen;
    • Goodman, William G.;
    • Herzog, Charles A.;
    • Kubo, Yumi;
    • London, Gerard M.;
    • Mahaffey, Kenneth W.;
    • Mix, Thomas-Christian;
    • Moe, Sharon M.;
    • Wheeler, David C.;
    • Parfrey, Patrick S.
    Publication type:
    Article